Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma.

Kajiyama H, Suzuki S, Utsumi F, Yoshikawa N, Nishino K, Ikeda Y, Niimi K, Yamamoto E, Kawai M, Shibata K, Nagasaka T, Kikkawa F.

Int J Clin Oncol. 2019 Aug;24(8):950-956. doi: 10.1007/s10147-019-01438-6. Epub 2019 Apr 2.

PMID:
30941534
2.

Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?

Kajiyama H, Mizuno M, Shibata K, Umezu T, Suzuki S, Yamamoto E, Mitsui H, Sekiya R, Niimi K, Kawai M, Nagasaka T, Kikkawa F.

Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:305-10. doi: 10.1016/j.ejogrb.2014.07.046. Epub 2014 Aug 20.

PMID:
25203309
3.

Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.

Kajiyama H, Suzuki S, Yoshikawa N, Kawai M, Nagasaka T, Kikkawa F.

Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:131-136. doi: 10.1016/j.ejogrb.2019.01.009. Epub 2019 Jan 17.

PMID:
30685661
4.

Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.

Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R, Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC, Maggioni A, Trope C, Sehouli J.

Ann Surg Oncol. 2013 Apr;20(4):1348-54. doi: 10.1245/s10434-012-2673-z. Epub 2012 Oct 2.

PMID:
23054114
5.

Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients.

Mizuno M, Kajiyama H, Shibata K, Mizuno K, Kawai M, Nagasaka T, Kikkawa F.

Br J Cancer. 2015 Apr 14;112(8):1376-83. doi: 10.1038/bjc.2015.97. Epub 2015 Mar 24.

6.

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer.

Mackay HJ, Brady MF, Oza AM, Reuss A, Pujade-Lauraine E, Swart AM, Siddiqui N, Colombo N, Bookman MA, Pfisterer J, du Bois A; Gynecologic Cancer InterGroup.

Int J Gynecol Cancer. 2010 Aug;20(6):945-52. doi: 10.1111/IGC.0b013e3181dd0110. Review.

PMID:
20683400
7.

"The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period".

Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Cuesta-Guardiola T, Peregrin I, Mendizabal E, Lizarraga S, Ortiz-Quintana L.

Surg Oncol. 2016 Mar;25(1):49-59. doi: 10.1016/j.suronc.2015.12.005. Epub 2016 Feb 10.

PMID:
26979641
8.

Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.

Fehm T, Banys M, Rack B, Janni W, Marth C, Blassl C, Hartkopf A, Trope C, Kimmig R, Krawczyk N, Wallwiener D, Wimberger P, Kasimir-Bauer S.

Int J Gynecol Cancer. 2013 Jun;23(5):839-45. doi: 10.1097/IGC.0b013e3182907109.

PMID:
23694981
9.

Extremely poor postrecurrence oncological outcome for patients with recurrent mucinous ovarian cancer.

Kajiyama H, Mizuno M, Shibata K, Kawai M, Nagasaka T, Kikkawa F.

Int J Clin Oncol. 2014 Feb;19(1):121-6. doi: 10.1007/s10147-013-0522-0. Epub 2013 Feb 8.

PMID:
23392995
10.
11.

Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.

Massad LS, Gao F, Hagemann I, Powell M.

Gynecol Obstet Invest. 2016;81(5):411-5. doi: 10.1159/000441791. Epub 2015 Nov 20.

12.

Prognosis in patients with serous and mucinous stage I borderline ovarian tumors.

Song T, Lee YY, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.

Int J Gynecol Cancer. 2012 Jun;22(5):770-7. doi: 10.1097/IGC.0b013e31824b4076.

PMID:
22426410
13.

Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.

Matsuo K, Machida H, Mandelbaum RS, Grubbs BH, Roman LD, Sood AK, Gershenson DM.

Gynecol Oncol. 2019 May;153(2):230-237. doi: 10.1016/j.ygyno.2019.02.003. Epub 2019 Feb 20.

PMID:
30797590
14.

Associations between residual disease and survival in epithelial ovarian cancer by histologic type.

Melamed A, Manning-Geist B, Bregar AJ, Diver EJ, Goodman A, Del Carmen MG, Schorge JO, Rauh-Hain JA.

Gynecol Oncol. 2017 Nov;147(2):250-256. doi: 10.1016/j.ygyno.2017.08.003. Epub 2017 Aug 16.

PMID:
28822556
15.

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.

Zang RY, Harter P, Chi DS, Sehouli J, Jiang R, Tropé CG, Ayhan A, Cormio G, Xing Y, Wollschlaeger KM, Braicu EI, Rabbitt CA, Oksefjell H, Tian WJ, Fotopoulou C, Pfisterer J, du Bois A, Berek JS.

Br J Cancer. 2011 Sep 27;105(7):890-6. doi: 10.1038/bjc.2011.328. Epub 2011 Aug 30.

16.

Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.

Risum S, Loft A, Engelholm SA, Høgdall E, Berthelsen AK, Nedergaard L, Lundvall L, Høgdall C.

Int J Gynecol Cancer. 2012 Sep;22(7):1163-9.

PMID:
22810969
17.

Long-term clinical outcome of patients with recurrent epithelial ovarian carcinoma: is it the same for each histological type?

Kajiyama H, Shibata K, Mizuno M, Umezu T, Suzuki S, Yamamoto E, Fujiwara S, Kawai M, Nagasaka T, Kikkawa F.

Int J Gynecol Cancer. 2012 Mar;22(3):394-9. doi: 10.1097/IGC.0b013e31823eed2c.

PMID:
22391762
19.

Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer.

Fotopoulou C, Richter R, Braicu IE, Schmidt SC, Neuhaus P, Lichtenegger W, Sehouli J.

Ann Surg Oncol. 2011 Jan;18(1):49-57. doi: 10.1245/s10434-010-1245-3. Epub 2010 Aug 10.

PMID:
20697821
20.

Mucinous carcinoma of the ovary. Clinicopathologic analysis.

Kikkawa F, Kawai M, Tamakoshi K, Suganuma N, Nakashima N, Furuhashi Y, Kuzuya K, Hattori S, Arii Y, Tomoda Y.

Oncology. 1996 Jul-Aug;53(4):303-7.

PMID:
8692534

Supplemental Content

Support Center